Last quarter (Q3 2024), Aethlon Medical's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Aethlon Medical's net income was $-3.47M. See Aethlon Medical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	-	$ 574.25K	$ 294.17K	$ 659.10K	$ 650.19K	$ 229.63K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	$ 574.25K	$ 294.17K	$ 659.10K	-	-
Operating Expense	$ 10.15M	$ 12.47M	$ 10.72M	$ 8.55M	$ 6.58M	$ 6.23M
Operating Income	$ -10.15M	$ -11.90M	$ -10.42M	$ -7.89M	$ -5.93M	$ -6.00M
Net Non Operating Interest Income Expense	$ 367.84K	$ 10.97K	-	$ -1.58K	$ -54.23K	$ -220.49K
Other Income Expense	-	$ 142.12K	-	-	$ -395.82K	-
Pretax Income	$ -9.78M	$ -12.03M	$ -10.42M	$ -7.89M	$ -6.38M	$ -6.22M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	$ -142.12K	-	-	-	-
Net Income Common Stockholders	$ -9.78M	$ -12.03M	$ -10.42M	$ -7.89M	$ -6.37M	$ -6.19M
Basic EPS	$ -2.73	$ -0.59	$ -0.71	-	$ -1.87	$ -5.13
Diluted EPS	$ -2.73	$ -0.59	$ -0.71	$ -0.65	$ -1.87	$ -5.13
Basic Average Shares	$ 29.31M	$ 20.54M	$ 14.76M	$ 12.09M	$ 3.41M	$ 1.21M
Diluted Average Shares	$ 29.31M	$ 20.54M	$ 14.76M	$ 12.09M	$ 3.41M	$ 1.21M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 10.15M	$ 12.47M	$ 10.72M	$ 8.55M	$ 6.58M	$ 6.23M
Net Income From Continuing And Discontinued Operation	$ -9.78M	$ -12.03M	$ -10.42M	$ -7.89M	$ -6.37M	$ -6.19M
Normalized Income	$ -9.68M	-	-	-	$ -5.98M	$ -6.19M
Interest Expense	-	-	-	-	$ 54.23K	$ 220.49K
EBIT	$ -9.78M	$ -12.03M	$ -10.42M	$ -7.89M	$ -6.33M	$ -6.00M
EBITDA	$ -9.51M	$ -11.79M	$ -10.30M	$ -7.85M	$ -6.30M	$ -5.97M

Currency in USD

Aethlon Medical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing